We developed a new quantitative system for diagnosis of invasive pulmonary
aspergillosis (IPA) using realtime automated polymerase chain reaction (PCR
). Intra-assay and interassay precision rates for in vitro examination were
2.53% and 2.20%, respectively, and the linearity of this assay was obtaine
d when there were > 20 copies/well. We examined 323 samples taken from 122
patients with hematological malignancies, including 33 patients with IPA an
d 89 control patients. Blood samples were subjected to PCR antigen detectio
n methods, using enzyme-linked immunosorbent assay (ELISA) and determinatio
n of plasma (1-->3)-beta -D-glucan (BDG) concentration. The sensitivities o
f PCR, ELISA, and BDG measurement for diagnosis of IPA were 79%, 58%, and 6
7%, respectively; the specificities were 92%, 97%, and 84%. Positive findin
gs on PCR preceded those of computed tomography by days, those of BDG measu
rement by days, and those of ELISA -0.3 +/- 6.6 by 2.8 +/- 4.1 days. Real-t
ime PCR was sensitive for IPA diagnosis, and quantitation was accurate.